ArticleHeliyon2022
Remediation of chlorinated aliphatic hydrocarbons (CAHs) contaminated site coupling groundwater recirculation well (IEG-GCW®) with a peripheral injection of soluble nutrient supplement (IEG-C-MIX) via multilevel-injection wells (IEG-MIW).
Article in Heliyon, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Tetrachloroethane (TeCA) removal through sequential graphite-mixed metal oxide electrodes in a bioelectrochemical reactor.Environmental science and ecotechnology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An innovative Groundwater Circulation Well (GCW) process was configured, installed, and tested for optimizing the distribution of a soluble nutrient supplement in a heterogeneous aquifer for reductive dehalogenation. This generated an in-situ bioreactor for the enhanced treatment of chlorinated aliphatic hydrocarbons (CAHs). At a site in Barcelona, Spain, trichloroethylene (TCE) concentration was found in the source area to a maximum value of up to 170 mg/L, while the degradation products like 1,2-dichloroethylene (1,2-DCE) and vinyl chloride (VC) were detected in significantly lower concentrations or were even absent. The novel system combined a vertical recirculation well (IEG-GCW®) and four multilevel injection wells (IEG-MIWs) to introduce the carbon solution into the aquifer. A 12 m deep IEG-GCW® equipped with 2 screened sections were located in the center of the 4 IEG-MIWs. The GCW induced flow moves the groundwater in an ellipsoidal recirculation cell to spread the supplements from the central GCW and from the peripheral MIWs in the aquifer body. Two multilevel sampling wells (IEG-MLSWs®) in the radius of influence (ROI) monitor the remediation process to capture hydrochemical variations along the vertical aquifer sections. A multi-source model harmonizes geological and hydrochemical information during different remediation stages, guiding the adaptation of the remediation strategy to physicochemical conditions and unmasking the decontamination mechanics induced by the remedial actions. Hydrochemical monitoring of MLWS and the stable carbon isotopic signature of cis-1,2-DCE and VC show the mobilization of secondary contamination sources triggered by recirculation during remediation, the stimulation of microbiological activity following nutrient supplement via GCW and MIWs, and the strong decrease of CAHs concentrations at different aquifer levels. Evidence from the first application at the field scale reveals a significant increase in the chloroethane biodegradation rate and short-term effectiveness of the innovative remediation strategy. GCW-MIWs synergy represents a promising strategy to degrade CAHs in a shorter period through the combination of a controllable hydraulic system, effective nutrient distribution, and the monitoring of the remediation process.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.